Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker... (d our expertise and intellectual propert...)

Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio

Date:8/23/2007

d our expertise and intellectual property will greatly enhance the collective ability of the companies to develop companion diagnostics to guide drug development and prescribing."

"This acquisition parallels what has been happening in the pharmaceutical industry for many years and should be regarded as being highly positive," said Professor Munir Pirmohamed, Professor of Clinical Pharmacology at The University of Liverpool. "It combines the forces of two well-known companies in this field and provides the infrastructure and expertise to improve the evidence base that is needed to incorporate pharmacogenetic diagnostics into clinical practice. I collaborate with both companies as academic-industrial collaborations are important in keeping with the research strategies of most governments and are ultimately needed to show the clinical validity and utility of pharmacogenetics for the management of expensive and complex disease areas. Hence, genes for drug transporters, such as MDR1 and OCT1 will prove to be as important as the Cytochrome P450 system in determining plasma and tissue levels of drugs, and thereby the efficacy and toxicity of drugs in disease areas including but not limited to oncology, cardiology, CNS, metabolic, and inflammatory diseases and pain."

About Clinical Data, Inc.

Clinical Data, Inc. is a global biotechnology company unlocking the potential of molecular discovery, from targeted science to better healthcare. Its PGxHealth division focuses on genetic test and biomarker development to help predict drug safety and efficacy, thereby reducing health care costs and improving clinical outcomes. Its Cogenics division provides molecular and pharmacogenomics services to both research and regulated environments. Its Vital Diagnostics division offers in vitro diagnostics solutions for the clinical laboratory. Through these divisions, Clinical Data is leveraging advances in molecular discovery to provide tangible benefits for patients, docto
'/>"/>

0

GOOD

Page: 1 2 3 4 5 6
Related biology technology :

1. BioRobot MDx standardize your automated protocols in clinical laboratories
2. What patients want: A story of choice, clinical trials & evidence-based medicine
3. ZyStor seeks to raise $15M for clinical trials
4. Prodesse begins clinical trials for flu virus detection
5. ConjuGon raises $3.3 million to fund clinical trials
6. Cancer-fighting agent heads for clinical trials
7. Quintessence cancer treatment chosen for clinical studies
8. Third Wave reports clinical growth, continued loss
9. Childrens expanding use of Sunrise Clinical Manager
10. Life-sciences conference to feature novel research with clinical potential
11. $14 million grant to drive clinical research at UW

Post Your Comments:

Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker...(d our expertise and intellectual propert...)